Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABEO Abeona Therapeutics Inc

盘后交易 03-27 18:30:26 EDT

4.29

-0.04

-0.92%

盘后4.28

-0.01-0.23%

16:45 EDT

最高4.39	最低4.29	成交量116.78万
今开4.32	昨收4.33	日振幅2.31%
总市值2.45亿	流通市值1.83亿	总股本5,705万
成交额504.45万	换手率2.74%	流通股本4,260万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABEO","market":"US","secType":"STK","nameCN":"Abeona Therapeutics Inc","latestPrice":4.29,"timestamp":1774641600000,"preClose":4.33,"halted":0,"volume":1167770,"hourTrading":{"tag":"盘后","latestPrice":4.2801,"preClose":4.29,"latestTime":"16:45 EDT","volume":8079,"amount":34674.478233,"timestamp":1774644312449,"change":-0.0099,"changeRate":-0.002308,"amplitude":0.011632},"delay":0,"changeRate":-0.009237875288683611,"floatShares":42603300,"shares":57049023,"eps":1.01,"marketStatus":"盘后交易","change":-0.04,"latestTime":"03-27 18:30:26 EDT","open":4.32,"high":4.39,"low":4.29,"amount":5044537.166749,"amplitude":0.023095,"askPrice":4.85,"askSize":340,"bidPrice":4.19,"bidSize":1,"shortable":3,"etf":0,"ttmEps":1.01,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774656000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.33,"preHourTrading":{"tag":"盘前","latestPrice":4.33,"preClose":4.33,"latestTime":"08:41 EDT","volume":11,"amount":47.63,"timestamp":1774615316061,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.2801,"preClose":4.29,"latestTime":"16:45 EDT","volume":8079,"amount":34674.478233,"timestamp":1774644312449,"change":-0.0099,"changeRate":-0.002308,"amplitude":0.011632},"volumeRatio":0.764014,"impliedVol":1.3661,"impliedVolPercentile":0.494},"requestUrl":"/m/hq/s/ABEO/wiki","defaultTab":"wiki","newsList":[{"id":"1195372622","title":"Abeona Therapeutics 全年营运收入为-8944.8万美元，远逊于Ibes预估的-7840万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195372622","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195372622?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:31","pubTimestamp":1773747071,"startTime":"0","endTime":"0","summary":"生物技术公司Abeona Therapeutics Inc公布的最新财务数据显示，其全年营运收入录得-8944.8万美元。这一表现显著低于市场研究机构Ibes此前预估的-7840万美元，凸显出公司在实现盈利方面仍面临挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"1127779905","title":"Abeona Therapeutics Inc：Zevaskyn 额外活检计划于本季度剩余时间进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1127779905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127779905?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:33","pubTimestamp":1773055992,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc 宣布，针对其研究性疗法 Zevaskyn 的额外活检计划已安排在本季度剩余时间内完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"1108449306","title":"Abeona Therapeutics® 公布业务进展，Zevaskyn® 商业上市势头持续增强","url":"https://stock-news.laohu8.com/highlight/detail?id=1108449306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108449306?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:31","pubTimestamp":1773055916,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc 近期发布了业务更新，重点强调了其基因疗法 Zevaskyn® 在商业上市过程中不断积累的积极势头。公司表示，相关准备工作正在稳步推进，市场初步反馈良好，为后续的商业化成功奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"gpt_icon":0},{"id":"1115322918","title":"Abeona Therapeutics第三季度运营收入为-2401.8万美元，低于Ibes预期的-1820万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115322918","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115322918?lang=zh_cn&edition=full","pubTime":"2025-11-12 20:32","pubTimestamp":1762950738,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics第三季度的运营收入为-2401.8万美元，而Ibes的预期为-1820万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"1174241986","title":"Abeona Therapeutics® 任命 James A. Gow 博士担任临床开发与医学事务高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1174241986","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174241986?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:31","pubTimestamp":1760963478,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics® 任命 James A. Gow 博士为临床开发及医学事务的高级副总裁，负责相关业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"1120146347","title":"Abeona Therapeutics宣布其治疗X连锁视网膜劈裂症的Abo-503基因疗法入选FDA罕见疾病终点推进试点项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1120146347","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120146347?lang=zh_cn&edition=full","pubTime":"2025-10-13 19:30","pubTimestamp":1760355017,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics公司宣布，其针对X连锁视网膜劈裂症(XLRS)的Abo-503基因疗法已被美国食品药品监督管理局(FDA)选中，纳入罕见疾病终点推进(RDEA)试点项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"2574550364","title":"Abeona Therapeutics Inc.盘中异动 大幅下跌5.04%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574550364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574550364?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:01","pubTimestamp":1760108519,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时01分，Abeona Therapeutics Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报5.38美元/股，成交量30.8826万股，换手率0.60%，振幅5.44%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010230159a6b32a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010230159a6b32a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEO","BK4139","LENZ","ABEOW","BK4007","BK4539"],"gpt_icon":0},{"id":"2517260910","title":"Abeona Therapeutics Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517260910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517260910?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185145,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Abeona Therapeutics Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报5.33美元/股，成交量6506股，换手率0.01%，振幅0.00%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为342.41%、257.25%、186.62%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Invivyd, Inc.，振幅分别为23.90%、13.51%、13.21%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223225abe9b0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223225abe9b0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEOW","ABEO","LENZ","BK4139"],"gpt_icon":0},{"id":"2517926917","title":"Abeona Therapeutics(ABEO.US)获奥本海默首次覆盖，给予优于大市评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517926917","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517926917?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:04","pubTimestamp":1741183446,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics(ABEO.US)获奥本海默首次覆盖，给予优于大市评级, 目标价16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05220448547630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ABEO"],"gpt_icon":0},{"id":"2506304699","title":"Abeona Therapeutics Inc.盘中异动 大幅拉升5.23%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506304699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506304699?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:05","pubTimestamp":1737993938,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时05分，Abeona Therapeutics Inc.股票出现波动，股价大幅拉升5.23%。截至发稿，该股报5.54美元/股，成交量9.3329万股，换手率0.21%，振幅5.29%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1969.92%、456.49%、218.44%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为86.84%、85.35%、65.16%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280005389612481b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280005389612481b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEOW","LENZ","ABEO","BK4139"],"gpt_icon":0},{"id":"2486087345","title":"Abeona Therapeutics Inc.盘中异动 股价大涨5.14%报6.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087345?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:08","pubTimestamp":1732720109,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时08分，Abeona Therapeutics Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报6.34美元/股，成交量7.1051万股，换手率0.16%，振幅4.89%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230830abe37c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230830abe37c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ABEO","ABEOW","BK4139"],"gpt_icon":0},{"id":"2471638995","title":"Abeona Therapeutics Inc.盘中异动 大幅拉升5.26%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471638995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471638995?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:08","pubTimestamp":1727705304,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时08分，Abeona Therapeutics Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报6.20美元/股，成交量7.7815万股，换手率0.18%，振幅5.26%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220824ab672922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220824ab672922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ABEOW","BK4139","ABEO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abeonatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0463},{"period":"1month","weight":-0.1981},{"period":"3month","weight":-0.2055},{"period":"6month","weight":-0.204},{"period":"1year","weight":-0.1323},{"period":"ytd","weight":-0.1784}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0615},{"period":"3month","weight":-0.0655},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1345},{"period":"ytd","weight":-0.054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abeona Therapeutics, Inc.于1974年在怀俄明州注册成立。该公司是一家处于商业阶段的生物制药公司，为危及生命的疾病开发细胞和基因疗法。2025年4月28日，美国食品药品监督管理局批准了ZEVASKYN（prademagene zamikeracel）基因修饰的细胞片，作为第一种也是唯一一种基于自体细胞的基因疗法，用于治疗成人和儿童RDEB患者的伤口，RDEB是一种严重且令人衰弱的遗传性皮肤病。RDEB无法治愈，ZEVASKYN是唯一一种经美国食品药品监督管理局批准的产品，可以一次性治疗RDEB伤口。ZEVASKYN被美国食品药品监督管理局授予孤儿药和罕见儿科疾病名称。","yearOnYearQuotes":[{"month":1,"riseRate":0.090909,"avgChangeRate":-0.103016},{"month":2,"riseRate":0.636364,"avgChangeRate":0.111579},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.011892},{"month":4,"riseRate":0.7,"avgChangeRate":0.022294},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010507},{"month":6,"riseRate":0.3,"avgChangeRate":0.003162},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.015738},{"month":8,"riseRate":0.636364,"avgChangeRate":0.073309},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.009981},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.003904},{"month":11,"riseRate":0.454545,"avgChangeRate":0.087228},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.137446}],"exchange":"NASDAQ","name":"Abeona Therapeutics Inc","nameEN":"Abeona Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abeona Therapeutics Inc(ABEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abeona Therapeutics Inc,ABEO,Abeona Therapeutics Inc股票,Abeona Therapeutics Inc股票老虎,Abeona Therapeutics Inc股票老虎国际,Abeona Therapeutics Inc行情,Abeona Therapeutics Inc股票行情,Abeona Therapeutics Inc股价,Abeona Therapeutics Inc股市,Abeona Therapeutics Inc股票价格,Abeona Therapeutics Inc股票交易,Abeona Therapeutics Inc股票购买,Abeona Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abeona Therapeutics Inc(ABEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}